A study has found that people with terminal lung or skin cancers lived twice as long if they received immunotherapy drugs – at the start of the day instead of after lunchtime.A study has found that people with terminal lung or skin cancers lived twice as long if they received immunotherapy drugs – at the start of the day instead of after lunchtime.Read MoreHealth News | Mail Online
![](https://ourbodyhealth.info/wp-content/uploads/2024/04/84237397-0-image-a-8_1714423274649-Mq3zBm.jpeg)